RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

Snauwaert et al. Supplementary Appendix

Snauwaert et al. Supplementary appendix provided by the authors.

Files in this Data Supplement:

• Adobe PDF - 2012.065581.SNAUWAERT_SUPPL.pdf